Pharmacotoxicology of monocyte-macrophage nanoformulated antiretroviral drug uptake and carriage

References

• Bartlett JA., Shao JF. 2009. Successes, challenges, and limitations of current antiretroviral therapy in low-income and middle-income countries. Lancet Infect Dis 9:637–649.
   PubMed Web of Science ®Google Scholar
• Beauliere A, Le Maux A, Trehin C, Perez F. 2010. Access to antiretroviral treatment in developing countries: Which financing strategies are possible? Rev Epidemiol Sante Publique 58:171–179.
   PubMedGoogle Scholar
• Beduneau A, Ma Z, Grotepas CB, Kabanov A, Rabinow BE, Gong N, Mosley RL, Dou H, Boska MD, Gendelman HE. 2009. Facilitated monocyte-macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticles. PLoS One 4:e4343.
   PubMed Web of Science ®Google Scholar
• Berg CJ, Michelson SE, Safren SA. 2007. Behavioral aspects of HIV care: Adherence, depression, substance use, and HIV-transmission behaviors. Infect Dis Clin North Am 21:181–200.
   PubMed Web of Science ®Google Scholar
• Blas-Garcia A, Apostolova N, Ballesteros D, Monleon D, Morales JM, Rocha M, Victor VM, Esplugues JV. 2010. Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells. Hepatology 52:115–125.
   PubMed Web of Science ®Google Scholar
• Chattopadhyay N, Zastre J, Wong HL, Wu XY, Bendayan R. 2008. Solid lipid nanoparticles enhance the delivery of the HIV protease inhibitor, atazanavir, by a human brain endothelial cell line. Pharm Res 25:2262–2271.
   PubMed Web of Science ®Google Scholar
• Chaudhuri A, Yang B, Gendelman HE, Persidsky Y, Kanmogne GD. 2008. STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood 111:2062–2072.
   PubMed Web of Science ®Google Scholar
• Chen L, Yokel RA, Hennig B, Toborek M. 2008. Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature. J Neuroimmune Pharmacol 3:286–295.
   PubMed Web of Science ®Google Scholar
• Conway B. 2007. The role of adherence to antiretroviral therapy in the management of HIV infection. J Acquir Immune Defic Syndr 45(Suppl. 1):S14–18.
   Google Scholar
• Darwich L, Esteve A, Ruiz L, Bellido R, Clotet B, Martinez-Picado J. 2008. Variability in the plasma concentration of efavirenz and nevirapine is associated with genotypic resistance after treatment interruption. Antivir Ther 13:945–951.
   PubMedGoogle Scholar
• Debbage P. 2009. Targeted drugs and nanomedicine: Present and future. Curr Pharm Des 15:153–172.
   PubMed Web of Science ®Google Scholar
• Dou H, Destache CJ, Morehead JR, Mosley RL, Boska MD, Kingsley J, Gorantla S, Poluektova L, Nelson JA, Chaubal M, Werling J, Kipp J, Rabinow BE, Gendelman HE. 2006. Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery. Blood 108:2827–2835.
   PubMed Web of Science ®Google Scholar
• Dou H, Grotepas CB, McMillan JM, Destache CJ, Chaubal M, Werling J, Kipp J, Rabinow B, Gendelman HE. 2009. Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS. J Immunol 183:661–669.
   PubMed Web of Science ®Google Scholar
• Dou H, Morehead J, Destache CJ, Kingsley JD, Shlyakhtenko L, Zhou Y, Chaubal M, Werling J, Kipp J, Rabinow BE, Gendelman HE. 2007. Laboratory investigations for the morphologic, pharmacokinetic, and anti-retroviral properties of indinavir nanoparticles in human monocyte-derived macrophages. Virology 358:148–158.
   PubMed Web of Science ®Google Scholar
• Dougherty GM, Rose KA, Tok JB, Pannu SS, Chuang FY, Sha MY, Chakarova G, Penn SG. 2008. The zeta potential of surface-functionalized metallic nanorod particles in aqueous solution. Electrophoresis 29:1131–1139.
   PubMed Web of Science ®Google Scholar
• Gendelman HE, Kabanov A, Linder J. 2008. The promise and perils of CNS drug delivery: A video debate. J Neuroimmune Pharmacol 3:58.
   PubMedGoogle Scholar
• Gendelman HE, Orenstein JM, Martin MA, Ferrua C, Mitra R, Phipps T, Wahl LA, Lane HC, Fauci AS, Burke DS, 1988. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med 167:1428–1441.
   PubMed Web of Science ®Google Scholar
• Ghosh S, Mashayekhi H, Pan B, Bhowmik P, Xing B. 2008. Colloidal behavior of aluminum oxide nanoparticles as affected by pH and natural organic matter. Langmuir 24:12385–12391.
   PubMed Web of Science ®Google Scholar
• Gorantla S, Dou H, Boska M, Destache CJ, Nelson J, Poluektova L, Rabinow BE, Gendelman HE, Mosley RL. 2006. Quantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug delivery. J Leukoc Biol 80:1165–1174.
   PubMed Web of Science ®Google Scholar
• Kanmogne GD, Primeaux C, Grammas P. 2005. HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: Implications for the pathogenesis of HIV-associated dementia. J Neuropathol Exp Neurol 64:498–505.
   PubMed Web of Science ®Google Scholar
• Kanmogne GD, Schall K, Leibhart J, Knipe B, Gendelman HE, Persidsky Y. 2007. HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: Implication for viral neuropathogenesis. J Cereb Blood Flow Metab 27:123–134.
   PubMed Web of Science ®Google Scholar
• Khemtong C, Kessinger CW, Gao J. 2009. Polymeric nanomedicine for cancer MR imaging and drug delivery. Chem Commun (Camb):3497–3510.
   PubMedGoogle Scholar
• Kiertiburanakul S, Sungkanuparph S. 2009. Emerging of HIV drug resistance: Epidemiology, diagnosis, treatment and prevention. Curr HIV Res 7:273–278.
   PubMed Web of Science ®Google Scholar
• Kim JY, Ammann A. 2004. Is the ‘3 by 5’ initiative the best approach to tackling the HIV pandemic? PLoS Med 1:e37.
   PubMedGoogle Scholar
• Kuo YC, Su FL. 2007. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles. Int J Pharm 340:143–152.
   PubMed Web of Science ®Google Scholar
• Moreno S, Lopez Aldeguer J, Arribas JR, Domingo P, Iribarren JA, Ribera E, Rivero A, Pulido F. 2010. The future of antiretroviral therapy: Challenges and needs. J Antimicrob Chemother 65:827–835.
   PubMed Web of Science ®Google Scholar
• Muthu MS, Singh S. 2009. Targeted nanomedicines: Effective treatment modalities for cancer, AIDS and brain disorders. Nanomedicine 4:105–118.
   PubMed Web of Science ®Google Scholar
• Nowacek A, Gendelman HE. 2009. NanoART, neuroAIDS and CNS drug delivery. Nanomedicine (Lond) 4:557–574.
   PubMed Web of Science ®Google Scholar
• Nowacek A, Kosloski LM, Gendelman HE. 2009a. Neurodegenerative disorders and nanoformulated drug development. Nanomedicine (Lond) 4:541–555.
   PubMed Web of Science ®Google Scholar
• Nowacek AS, Miller RL, McMillan J, Kanmogne G, Kanmogne M, Mosley RL, Ma Z, Graham S, Chaubal M, Werling J, Rabinow B, Dou H, Gendelman HE. 2009b. NanoART synthesis, characterization, uptake, release and toxicology for human monocyte-macrophage drug delivery. Nanomedicine (Lond) 4:903–917.
   PubMed Web of Science ®Google Scholar
• Rebiere H, Mazel B, Civade C, Bonnet PA. 2007. Determination of 19 antiretroviral agents in pharmaceuticals or suspected products with two methods using high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 850:376–383.
   PubMed Web of Science ®Google Scholar
• Sandelowski M, Voils CI, Chang Y, Lee EJ. 2009. A systematic review comparing antiretroviral adherence descriptive and intervention studies conducted in the USA. AIDS Care 21:953–966.
   PubMed Web of Science ®Google Scholar
• Slowing I, Trewyn BG, Lin VS. 2006. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J Am Chem Soc 128:14792–14793.
   PubMed Web of Science ®Google Scholar
• UNAIDS. 2009. AIDS epidemic update. UNAIDS/09.36E / JC1700E.
   Google Scholar
• Vallhov H, Gabrielsson S, Stromme M, Scheynius A, Garcia-Bennett AE. 2007. Mesoporous silica particles induce size dependent effects on human dendritic cells. Nano Lett 7:3576–3582.
   PubMed Web of Science ®Google Scholar
• Waters L, Nelson M. 2007. Why do patients fail HIV therapy? Int J Clin Pract 61:983–990.
   PubMedGoogle Scholar
• Weller DR, Brundage RC, Balfour HH Jr, Vezina HE. 2007. An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 848:369–373.
   PubMed Web of Science ®Google Scholar